Computer-aided polyp detection cuts adenoma and sessile serrated lesion miss rates
FRIDAY, Oct. 1, 2021 (HealthDay News) — Computer-assisted colonoscopies reduce rates of missed lesions, according to a study published online Sept. 13 in Clinical Gastroenterology and Hepatology.
Jeremy R. Glissen Brown, M.D., from Beth Israel Deaconess Medical Center in Boston, and colleagues randomly assigned 223 patients presenting for colorectal cancer screening or surveillance to either artificial intelligence-based computer-aided polyp detection (CADe) colonoscopy first or high-definition white light (HDWL) colonoscopy first, followed immediately by the other procedure in tandem fashion by the same endoscopist.
The researchers found that the adenoma miss rate was lower in the CADe-first group versus HDWL-first group (20.12 versus 31.25 percent; odds ratio, 1.8048). The sessile serrated lesion miss rate also was lower in the CADe-first group (7.14 versus 42.11 percent). Furthermore, the CADe-first group had a higher rate of first-pass adenomas per colonoscopy (1.19 versus 0.90) and first-pass adenoma detection rate (50.44 versus 43.64 percent).
“Our study demonstrates that computer-aided polyp detection has the potential to decrease variability in colonoscopy quality among providers by reducing the miss rate even for experienced physicians,” a coauthor said in a statement.
Two authors disclosed financial ties to the medical imaging technology industries.
Surveillance Colonoscopy at Five Years After Adenoma Removal Noninferior to Three Years 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population 
H. Pylori Exposure May Contribute to Global Burden of Colorectal Cancer 
Lower Breast, Cervical Cancer Screening Seen for Adults With Disabilities 
Mammography Trials Yield Excess-Incidence Patterns Consistent With Low Overdiagnosis 
Alcohol-Attributable Cancer Mortality Has Increased Significantly in the U.S. 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
Chemo-Free Combo of Four Targeted Therapies Shows Promise in Metastatic Breast Cancer 
